Intravenous Atropine in Reducing Reperfusion Arrhythmias, Conduction Abnormalities and Hypotension in Inferior ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 158 participants.
Also called NCT07268586
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 158 participants
- Sponsor
- Registry
-
NCT07268586
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Egypt
- Registry status
- Completed
Technical summary
Registry record NCT07268586. Randomized; triple masking; primary purpose prevention. Start 2025-08-01 (actual); primary completion 2026-02-28 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Intravenous Atropine in Reducing Reperfusion Arrhythmias, Conduction Abnormalities and Hypotension in Inferior ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
- Condition
- Myocardial Infarction
- Intervention (Drug)
- Intravenous atropine immediately before wire crossing during primary percutaneous coronary intervention
- Intervention (Drug)
- Intravenous normal saline as placebo immediately before wire crossing during primary percutaneous coronary intervention
- Lead sponsor
- Ain Shams University
Record details
- Record id
cardio:ct-nct07268586- Content hash
b47c202ec169058148a09145da9707ba7874dfceff7c6ec3787e35bd2306ca78